SoundHealth's primary technology revolves around the SONU Band, which utilizes Acoustic Resonance Therapy to provide relief from nasal congestion. This innovative device is the first of its kind to receive FDA approval for vibrational sound therapy aimed at alleviating symptoms associated with both allergic and non-allergic rhinitis. The SONU Band operates by emitting resonant sound waves that induce subtle vasoconstriction, thereby reducing inflammation, enhancing mucociliary clearance, and opening nasal airways. This non-invasive approach offers a drug-free alternative for individuals seeking relief from moderate to severe nasal congestion.

The effectiveness of the SONU Band is supported by clinical studies and endorsements from medical professionals, including ENT specialists and allergists. Research published in reputable journals highlights the safety and efficacy of acoustic resonance therapy in treating nasal congestion. The technology is designed for ease of use, allowing individuals to initiate therapy by simply scanning their face and activating the device. This user-friendly interface, combined with the backing of scientific research, positions the SONU Band as a trusted solution for those looking to manage their nasal congestion without relying on medications or sprays.

United States

SoundHealth is on a mission to help the world breathe free. As a startup, we specialize in AI-based, personalized, drug-free treatment designed to improve respiratory health. SoundHealth is founded by an experienced team of serial entrepreneurs in the technology and medical fields. SoundHealth's inaugural product, SONU, is the world's first FDA-authorized wearable device offering drug-free, spray-free, personalized relief from nasal congestion.

SoundHealth

Company Details